Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Yorke
    Yorke
  10. Wu
    Wu

Groups

  1. Department of Medicine (4609)
  2. Surgery (3547)
  3. Survivorship Research (2657)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2123)
  6. GSK Faculty (1936)
  7. Center for Hematologic Malignancies (1671)
  8. Hematologic Malignancies, Division of (1608)
  9. Gynecology Disease Management Team (1426)
  10. Sloan Kettering Institute Faculty (1398)
Search Within
Formats
  1. Journal Article (7381)
  2. Meeting Abstract (4692)
  3. Review (615)
  4. Book Section (538)
  5. Editorial (251)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4609)
  2. Surgery (3547)
  3. Survivorship Research (2657)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2123)
  6. GSK Faculty (1936)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (244)
  2. 2024 (783)
  3. 2023 (760)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2611)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (967)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (525)
  6. Journal of Sexual Medicine (435)

More Publications

Results (13847)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Primary analysis of the confirmatory VISION cohort C
    Meeting Abstract

    Thomas, M.; Garassino, M.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E.; Mazieres, J.; Cortot, A.; Raskin, J.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Phase I A study to evaluate GDC-6036 monotherapy in patients with non-small cell lung cancer (NSCLC) with KRAS G12C mutation
    Meeting Abstract

    Sacher, A.; Patel, M. R.; Miller, W. H. Jr; Desai, J.; Garralda, E.; Bowyer, S.; Kim, T. W.; De Miguel, M.; Falcon, A.; Krebs, M. G.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Germline risk assessment and genetic counseling in ovarian cancer patients of diverse self-reported race/ethnicity and ancestry
    Meeting Abstract

    Sia, T.; Maio, A.; Gordhandas, S.; Kahn, R.; Kemel, Y.; Salo-Mullen, E.; Sheehan, M.; Tejada, P. R.; Roche, K. L.; Chi, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Neratinib efficacy in patients with EGFR exon 18-mutant non-small-cell lung cancer: Findings from the SUMMIT basket trial
    Meeting Abstract

    Goldman, J.; Bueno, A. M.; Dooms, C.; Jhaveri, K.; de Miguel, M. J.; Piha-Paul, S. A.; Unni, N.; Mahipal, A.; Suga, J. M.; Naltet, C.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) - Phase 2 study of MLN0128 (TAK-228) in patients with tumors with TSC1 or TSC2 mutations: Sub-protocol EAY131-M
    Meeting Abstract

    Hays, J.; Song, Z.; Paik, P.; Iyer, G.; Mitchell, E.; Wright, J.; Doyle, L.; Gray, R.; Wang, V.; McShane, L.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model
    Meeting Abstract

    Odintsov, I.; Liu, A.; Khodos, I.; Chang, Q.; Giuliano, C.; Mattar, M.; Vojnic, M.; Bonifacio, A.; De Stanchina, E.; Lovati, E.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Preliminary results from FLAGSHP-1: A phase I dose escalation study of ERAS-601, a potent SHP2 inhibitor, in patients with previously treated advanced or metastatic solid tumors
    Meeting Abstract

    McKean, M.; Barve, M.; Hong, D.; Parikh, A.; Rosen, E.; Yang, J.; Picard, R.; Yi, J.; Brail, L.; Vecchio, D.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Regulation of oncogenic transcription and tumor growth in pediatric cancers by the CDK9 inhibitor KB-0742
    Meeting Abstract

    Saffran, D.; Poon, E.; Ibanez, G.; Nakashima, J.; Amara, S. N. A.; Noe, C.; Hood, T.; Kumar, P.; DiMartino, J.; Dela Cruz, F.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • A radiohapten capture system for CAR T cells that tracks them in vivo and improves efficacy
    Meeting Abstract

    Kurtz, K.; Eibler, L.; Dacek, M.; Carter, L.; Cheal, S.; Veach, D.; Qureshy, S.; Han, J.; Reynaud, E.; Verma, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Safety and preliminary clinical activity of NVL-520, a highly selective ROS1 inhibitor, in patients with advanced ROS1 fusion-positive solid tumors
    Meeting Abstract

    Drilon, A.; Besse, B.; Camidge, D. R.; Ou, S. H. I.; Gadgeel, S. M.; Johnson, M. L.; Calles, A.; de Miguel, M. J.; Spira, A. I.; Felip, E.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save